Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.
Researchers
Rahul Banerjee, Matthew C Cheung, Benjamin Derman, Hans Messersmith, Samer Al Hadidi, Sita Bhella, Cynthia Chmielewski, Mohammad S Ebraheem, C Todd Kennedy, Shaji Kumar, Alan Langerak, Brea Lipe, Hira Mian, Eloisa Riva, Rahul Seth, Latha Subramanian, Saad Z Usmani, Tanya M Wildes, Saurabh Zanwar, Ying Zhuo, Lisa K Hicks
Abstract
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the <i>ASCO Guidelines Methodology Manual</i>. ASCO Living Guidelines follow the <i>ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines</i>. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (<i>Appendix I</i> and <i>Appendix II</i>). Updates are published regularly and can be found on the <i>ASCO Publications website</i>.Source: PubMed (PMID: 42160714)View Original on PubMed